Aurobindo Pharma is down in the deep red today. After Sun Pharma, it is the turn of Aurobindo Pharma today. The stock opened in the red today at Rs.598.90, going down further to hit a new low at Rs.560.60.
Like Sun, Aurobindo too got observations from US FDA – Sun got 10 and Aurobindo for 6.
The company said that the FDA had inspected its oral manufacturing facility situated at Jedcherla, Hyderabad, from 2nd to 10th May 2022. At the end of the inspection, it was issued a ‘Form 483’ with six observations.
The company said that it will respond to the US FDA within the stipulated timeline and work closely with US FDA to close the observations.